In vivo alterations in cytokine production following interleukin-12 (IL- 12) and anti-IL-4 antibody treatment of CB6F1 mice with chronic cutaneous leishmaniasis

Infection and Immunity

Volumn 64, Issue 12, 1996, Pages 5248-5254

  Li, Jian ^a   Scott, Phillip ^a   Farrell, Jay P ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 4; MESSENGER RNA; MONOCLONAL ANTIBODY; RECOMBINANT INTERLEUKIN 12; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FEMALE; INFECTION RESISTANCE; INTRAPERITONEAL DRUG ADMINISTRATION; LEISHMANIA MAJOR; LYMPH NODE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SKIN LEISHMANIASIS;

EID: 0029825437     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.64.12.5248-5254.1996     Document Type: Article

References (29)

1. Assoian, R. K., B. E. Fleurdelys, H. C. Stevenson, P. J. Miller, D. K. Madtes, E. W, Raines, R. Ross, and M. B. Sporn. 1997. Expression and secretion of the beta transforming growth factor by activated human macrophages. Proc. Natl. Acad. Sci. USA 84:6020.
2. Batuman, O. A., A. Ferrero, C. Cupp, S. A. Jimenez, and K. Khalill. 1995. Differential regulation of transforming growth factor ß-1 genc expression by glucocorticoids in human T and glial cells. J. Immunol 155:4397-4405.
3. Carvalho, E. M., O. Bacellar, C. Brownell, T. Regis, R. L. Coffman, and S. G, Reed. 1994. Restoration of IFN-y production and lymphocyte proliferatior. in visceral leishmaniasis. J. Immunol. 152:5949-5956.
4. Chatelain, R., K. Varkila, and R. L. Coffman, 1992. IL-4 induces a Th2 response in Leishmania major-infected mice. J. Immunol. 148:1182-1187.
5. Detolla, L. J., Jr., P. A. Scott, and J. P. Farrell. 1981. Single gene control of resistance to cutaneous leishmaniasis in mice. Immunogenetics 14:29-39.
6. Flnkelman, F. D., J. Holmes, I. M. Katona, J. Urban, M. P. Beckmann, L. S. Park, K. A. Schooley, R. L. Coffman, T. R. Mosmann, and W. E. Paul. 1990. Lymphokine regulation of in vivo immunoglobulin isotype selection. Annu. Rev. Immunol. 8:303-333.
7. Gazzinelli, R. T., S. Helny, T. A. Wynn, S. Wolf, and A. Sher. 1993. Interleukin 12 is required for the T-lymphocyte-independent induction of interferon γby an intracellular parasite and induces resistance in T-cell-deficient hosts. Proc. Natl. Acad. Sci. USA 90:6115-6119.
8. Guler, M. L., J. D. Gorham, C.-S. Hsieh, A. J. Mackey, R. G. Steen, W. F. Dietrich, and K. M. Murphy. 1996. Genetic susceptibility to Leishmania: IL-12 responsiveness in Th1 cell development. Science 271:984-987.
9. Heinzel, F. P., M. D. Sadick. B. J. Holaday, R. L. Coffman, and R. M. Locksley. 1989. Reciprocal expression of Interferon-y or interleukin 4 during the resolution or progression of murine leishmaniusis. J. Exp. Med. 169:59-72.
10. Heinzel, F. P., M. D. Sadick, S. S. Mutha, and R. M. Locksley. 1991. Production of Interferon y, interleukin 2, interleukin 4, and interleukin 10 by CD4 lymphocytes in vivo during healing and progressive murine leishmaniasis. Proc. Natl. Acad. Sci. USA 88:7011-7015.
11. Heinzel, F. P., D. S. Schoenhaut, R. M. Rerko, L. E. Rosser, and M. K. Gately. 1993. Recombinant interleukin 12 cures mice infected with Leishmania major. J. Exp. Med. 177:1505-1509.
12. Howard, J. G., C. Hale, and W. L. Chan-Liew. 1980. Immunological regulation of experimental cutaneous leishmaniasis. I. Immunogenetic aspects of susceptibility ID Leishmania tropica in mice. Parasite Immunol. 2:303-314.
13. Hseih, C.-S., S. E. Macatonia, A. O'Garra, and K. M. Murphy. 1995. T cell genetic background determines default T helper phenotype development in vivo. J. Exp. Med. 181:713-721.
14. Hunter, C. A., L. Bermudez, H. Beernink, W. Waegell, and J. S. Hemmington. 1995. Transforming growth factor-ß inhibits interleukin-12-induccd production of interferon-y by natural killer cells: a role for transforming growth factor-ß in the regulation of T cell-independent resistance to Toxuplasma gondii. Eur. J. Immunol. 25:994-1000.
15. Moore, K. J., and G. Mallashewski. 1994. Intracellular infection by Leishmania donovani inhibits macrophage apoptosis. J. Immunol. 152:2930-2937.
16. Nabors, G. S., L. C. C. Afonso, J. P. Farrell, and P. Scott. 1994. Switch from a type 2 to a type 1 T helper cell response and cure of established Leishmania major infection in mice is induced by combined therapy with interleukin 12 and Pentostam. Proc. Natl. Acad. Sci. USA 92:3142-3146.
17. Nabors, G. S., and J. P. Farrell. 1996. Successful chemotherapy in experimental leishmaniasis is influenced by the polarity of the T cell response before treatment. J. Infect. Dis. 173:979-986.
18. Nabors. G. S., T. Nolan, W. Croop, J. LI, and J. P. Farrell. 1995. The influence of the site of parasite inoculation on the development of Th1 and Th 2 type immune responses in (BALB/c × C57BL/6) F1 mice infected with Lieshmania major. Parasite Immunol. 17:569-579.
19. Openshaw, P., E. E. Murphy, N. A. Hosken, V. Maino, K. Davls, K. Murphy, and A. O'Garra. 1995. Heterogeneity of intracellular cytokine synthesis at the single-cell level in polarized T helper l and T helper 2 populations. J. Exp. Mod. 182:1357-1367.
20. Sacks, D. L., S. Heiny, and A. Sher. 1985. Identification of cell surface carbohydrate and antigenic changes between noninfective and infective developmental stages of Leishmania major promastigotes. J. Immunol. 135: 564-569.
21. Sadick, M. U., F. P. Heinzel, B. J. Holaday, R. T. Pu, K. S. Dawkins, and K. M. Locksley. 1990. Cure of murine leishmaniasis with anti-interleukin 4 monoclonal antibody, Evidence for a T cell-dependent, Interferon gammaindependent mechanism. J. Exp. Med. 171:115-125.
22. Scharton-Kersten, T., L. C. C. Afonso, M. Wysocka, G. Trinchieri, and P. Scott. 1995.1L-12 is required for natural killer cell activation and subsequent T helper 1 cell development in experimental leishmaniasis. J. Immunol. 154:5320-5330.
23. Scott, P., P. Natovitz, R. L. Coffman, E. Pearce, and A. Sher. 1988. Immunoregulation of cutaneous leishmaniasis: T cell lines that transfer protective immunity or exacerbation belong to different T helper subsets and respond to distinct parasite antigens. J. Exp. Med. I68:l675-l684.
24. Scott, P., E. Pearce, P. Natovltz, and A. Sher. 1987. Vaccination against cutaneous leishmaniasis in a murine model: I. Induction of protective immunity with a soluble extract of promastigotes. J. Immunol. 139:221-227.
25. Stenger, S., H. Thuring, M. Rollinghoff, and C. Bogdan, 1994. Tissue expression of inducible nitric oxide synthase is closely associated with resistance to Leishmania major. J. Exp. Med. 180:783-793.
26. Sypek, J. P., C. L. Chung, S. E. H. Mayor, J. M. Subramanyam, S. J. Goldman, D. S. Sleburth, S. F. Wolf, and R. G. Schaub. 1993. Resolution of cutaneous leishmaniasis: interleukin 12 initiates a protective T helper type 1 immune response. J. Exp. Med. 177:1797-1802.
27. Trinchieri, G. 1995. Interleukin 12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity. Annu. Rev. Immunol. 13:251-276.
28. Wang, Z.-E., S. Zheng, D. B. Corry, D. K. Dalton, R. A. Seder, S. L. Reiner, and R. M. Locksley. 1994. Interferon-γ-independent effects of interleukin 12 administered during acute or established infection due to Leishmania major. Proc. Natl. Acad, Sci. USA 91:12932-12936.
29. Wynn, T. A., I. Eltoum, A. W. Cheever, F. A. Lewis, W. C. Gause, and A. Sher. 1993. Analysis of cytokine mRNA expression during primary granuloma formation induced by eggs of Schistosoma mansoni. J. Immunol. 151:1430-1440.